bluebird bio (BLUE) call put ratio 6.8 calls to 1 put into confirms FDA approval of Zynteglo

bluebird bio (NASDAQ: BLUE) 30-day option implied volatility is at 192; compared to its 52-week range of 61 to 184 into confirms FDA approval of Zynteglo. Call put ratio 6.8 calls to 1 put.

You May Also Be Interested In

• Black Hills Corp. (BKH) 3500 contracts of October 80 calls active, share price up 2.5%
• Bloom Energy Corp. (BE) call put ratio 1.2 calls to 1 put as share price up 1.2%
• Amphastar Pharma (AMPH) 6300 contracts of October calls trade